Document Detail


Epileptogenic activity of folic acid after drug induces SLE (folic acid and epilepsy)
MedLine Citation:
PMID:  9758264     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To study the effect of folic acid-containing multivitamin supplementation in epileptic women before and during pregnancy in order to determine the rate of structural birth defects and epilepsy-related side effects. STUDY DESIGN: First a randomised trial, later periconception care including in total 12225 females. RESULTS: Of 60 epileptic women with periconceptional folic acid (0.8 mg)-containing multivitamin supplementation, no one developed epilepsy-related side effects during the periconception period. One epileptic woman delivered a newborn with cleft lip and palate. Another patient exhibited with a cluster of seizures after the periconception period using another multivitamin. This 22-year-old epileptic woman was treated continuously by carbamazepine and a folic acid (1 mg)-containing multivitamin from the 20th week of gestation. She developed status epilepticus and later symptoms of systemic lupus erythematodes. Her pregnancy ended with stillbirth. CONCLUSIONS: The epileptic pregnant patient's autoimmune disease (probably drug-induced lupus) could damage the blood-brain barrier, therefore the therapeutic dose (> or =1 mg) of folic acid triggered a cluster of seizures. Physiological dose (<1 mg) of folic acid both in healthy and 60 epileptic women, all without any autoimmune disease, did not increase the risk for epileptic seizures.
Authors:
E Eros; P Géher; B Gömör; A E Czeizel
Related Documents :
20838574 - Folic acid supplementation stimulates notch signaling and cell proliferation in embryon...
97234 - Adjuvant activity of synthetic 6-o-"mycoloyl"-n-acetylmuramyl-l-alanyl-d-isoglutamine a...
19757214 - Folic acid supplementation for the prevention of recurrence of colorectal adenomas: met...
15151734 - Risk of fetal exposure to folic acid antagonists.
16279764 - 7-(1,1-dimethylethyl)-6-(2-ethyl-2h-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4...
16557994 - Comparison of the effects of a synthetic polyribonucleotide with the effects of endotox...
Publication Detail:
Type:  Case Reports; Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  European journal of obstetrics, gynecology, and reproductive biology     Volume:  80     ISSN:  0301-2115     ISO Abbreviation:  Eur. J. Obstet. Gynecol. Reprod. Biol.     Publication Date:  1998 Sep 
Date Detail:
Created Date:  1998-12-03     Completed Date:  1998-12-03     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0375672     Medline TA:  Eur J Obstet Gynecol Reprod Biol     Country:  IRELAND    
Other Details:
Languages:  eng     Pagination:  75-8     Citation Subset:  IM    
Affiliation:
Department of Human Genetics and Teratology, National Institute of Public Health - WHO Collaborating Centre for the Community Control of Hereditary Diseases, Budapest, Hungary.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abortion, Spontaneous
Anticonvulsants / administration & dosage,  therapeutic use
Dietary Supplements
Double-Blind Method
Drug Interactions
Epilepsy / chemically induced*,  drug therapy
Female
Folic Acid / administration & dosage,  adverse effects*
Humans
Lupus Erythematosus, Systemic / chemically induced*,  immunology
Pregnancy
Pregnancy Complications*
Vitamins / administration & dosage
Chemical
Reg. No./Substance:
0/Anticonvulsants; 0/Vitamins; 59-30-3/Folic Acid
Comments/Corrections
Comment In:
Eur J Obstet Gynecol Reprod Biol. 2000 Feb;88(2):217-9   [PMID:  10690685 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Malignant fibrous histiocytoma of the stomach during pregnancy: a case report.
Next Document:  Within-subject variability of differences between conventional and automated blood pressure measurem...